DOSSIER · UPDATED 18 NOV 2025

Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health…

gilgameshpharmaceutical.com ↗Claim this profile
Founded
2019
Headcount
24
Open roles
0
Last raised
Grant · $14M
SECTION I · THE BRIEF

Inside Gilgamesh Pharmaceuticals

Brief #89604Updated 18 NOV 2025NEW YORKY COMBINATORGRANT
Employbl Dossier

Gilgamesh Pharmaceuticals

Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy.…

Founded
2019
Headcount
24
Open roles
0
Last raised
Grant · $14M
Section II — RestrictedMembers only
  • Engineering interview process at Gilgamesh Pharmaceuticals
  • Tech stack & infrastructure choices
  • Culture & day-to-day work style
  • Why join now vs. 6 months from now
  • Hiring focus & open headcount by team
  • Comp philosophy and band context
Open Gilgamesh Pharmaceuticals briefSign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Andrew KruegelAndrew Kruegel
Jonathan SpornJonathan Sporn
Jeff Witkin
Mike Cunningham
Dalibor Sames
OPEN ROLES

Hiring at Gilgamesh Pharmaceuticals

Current Job Listings

Listing 0 of 0 job openings
We don't currently have any jobs listed for this company. We suggest visiting the Jobs Search page if you are looking for exciting new tech and startup opportunities.
FUNDING

Capital raised

Total Amount Raised: $82,559,840

Gilgamesh Pharmaceuticals' Investors

Gilgamesh Pharmaceuticals Funding Rounds

  • Grant

    $14,000,000

  • Grant

    $14,000,000

    Grant Investors

    National Institute on Drug Abuse (NIDA)

  • Series B

    $39,000,000

  • Series B

    $39,000,000

    Series B Investors

    Prime Movers Lab
    Gron Ventures
    Negev Capital
    Alumni Ventures Group
    Palo Santo
    Satori Capital
    Route 66 Ventures
    JLS Fund
    WPSS.bio

  • Series A

    $27,000,000

  • Series A

    $27,000,000

    Series A Investors

    Prime Movers Lab
    Noetic Fund
    Route 66 Ventures
    Gron Ventures
    JLS Fund
    Palo Santo
    Gaingels
    Alumni Ventures Group

  • Seed

    $125,000

  • Seed

    $125,000

    Seed Investors

    Y Combinator
    What If Ventures
    Offline Ventures
    Bossa Invest
    Incisive Ventures

  • Seed

    $2,434,845

  • Seed

    $2,434,845

    Seed Investors

    Rand Hindi
    Noveus Capital
Funding info provided by Diffbot.
TAGS

Categorized in

Company Collections

These are collections Gilgamesh Pharmaceuticals is a part of. Click on the collection name to view similar companies.

Gilgamesh Pharmaceuticals' Investors

Gilgamesh Pharmaceuticals' Industries

LOCATIONS

Where they work

Gilgamesh Pharmaceuticals Headquarters Location

113 University Pl, New York, NY, 10003

Loading map…